Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6535)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2018 (publication date) through May 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Neokosmidis G, Tziomalos K. Role of cenicriviroc in the management of nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(48): 5415-5417 [PMID: 30622370 DOI: 10.3748/wjg.v24.i48.5415] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i48/5415.htm |
| Number | Citing Articles |
| 1 |
Michael Doulberis, Kasiani Papadimitriou, Apostolis Papaefthymiou, Jannis Kountouras, Stergios A. Polyzos. The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis. Exploration of Medicine 2020; 1(4): 170 doi: 10.37349/emed.2020.00012
|
| 2 |
Zhiyu Wu. Non-alcoholic Fatty Liver Disease: Pathology, Disease Models and Therapies. Highlights in Science, Engineering and Technology 2023; 36: 347 doi: 10.54097/hset.v36i.5702
|
| 3 |
Laura Draijer, Marc Benninga, Bart Koot. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Review of Gastroenterology & Hepatology 2019; 13(5): 447 doi: 10.1080/17474124.2019.1595589
|
| 4 |
Upasna Madan, Bhawna Verma, Amit Awasthi. Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells. European Journal of Immunology 2024; doi: 10.1002/eji.202350847
|